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  Abstract 
    Aim.   The harmful effect of hypocapnia on the neonatal brain emphasizes the importance of monitoring arterial carbon 
dioxide tension (PaCO2). Transcutaneous monitoring of carbon dioxide (tcPCO2) reduces the need for arterial blood 
sampling. Drawbacks are high electrode temperature causing risks of skin burning. The aim was to determine the accuracy 
and precision of tcPCO2 at reduced electrode temperature.   Methods.   Forty newborns (GA 24.9  –  41.7) were included. 
Two tc-monitors were applied (TCM4, Radiometer, Copenhagen). Arterial blood gas sampling and monitoring of tcPCO2-
level at different electrode temperatures was done simultaneously (39  °  C, 40  °  C, 41  °  C, 42  °  C, 44  °  C). Difference of 
PaCO2     tcPCO2 was expressed as a percentage of the mean.   Results.   Mean PaCO2 was 5.8kPa [3,2; 7.9]. Bias (PaCO2      
tcPCO2) increased from 5% at 44  °  C to 17% at 39  °  C, but did not differ signiﬁ  cantly between 41  °  C and 40  °  C. The 
precision of the tcPCO2 at each temperature ranged from     7  –  10%. After correction for the temperature-dependent over-
reading, we found increasing PaCO2      tcPCO2 difference with increasing PaCO2, approx. 2% pr. kPa increase of CO  2 . 
Only mild transient erythema was observed.   Conclusion.   A lower electrode temperature in tcPCO2-monitoring increases 
systematic overreading of the tc-electrode. However, in very preterm babies, monitoring at 40  °  C or 41  °  C is possible 
provided a bias correction of 12  –  15% is applied.   
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    Introduction 
  The harmful effects of hyperventilation and hypo-
capnia on the neonatal brain emphasize the impor-
tance of a stable arterial carbon dioxide tension 
(PaCO2) especially in mechanically ventilated new-
borns [1]. Transcutaneous monitoring (TCM) allows 
continuous monitoring of the transcutaneous carbon 
dioxide (tcPCO2)   –   a surrogate measure of the 
PaCO2. Hence, the need of arterial blood sampling 
is reduced. 
  The transcutaneous electrode conventionally is 
heated to 44  °  C to arterialize the capillary bed. The 
correlation between tcPCO2 and PaCO2 depends on 
the temperature in the capillary bed, the blood ﬂ  ow 
to the skin, and the local metabolic production of 
CO  2  . Drawbacks of the high electrode temperature 
are risk of skin burns [2,3]. The correlation between 
time and surface temperature in the causation of 
cutaneous burns has been known for a long time [4]. 
Early studies in preterm infants showed a direct 
correlation between the duration of electrode appli-
cation and persistence of erythema; while the appli-
cation time is shortened [2]. Besides disturbance of 
the neonate, relocation of the electrode gives unstable 
values during stabilization. 
  In the early era of transcutaneous monitoring, 
several studies were performed, improving the mon-
itors in use today [5,6]. This also includes studies 
with monitoring at different electrode temperatures 
[7  –  9]. Because of the fragile skin of preterm infants 
a lower electrode temperature would be appreciated. 
This could reduce the risk of skin burns and prolong 
the application time. However, a recent study in 
adults examined reduced electrode temperature 
using the TCM4, Radiometer Medical ApS, Denmark 
[10]. Due to bias, the authors concluded that the 
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electrode should be heated to at least 43  °  C to measure 
reliable tcPCO2 [10]. 
  The aim of this study was to determine the accu-
racy and precision of tcPCO2 in preterm infants 
using TCM4, Radiometer Medical ApS, Denmark, 
with reduced electrode temperatures. Our assump-
tion was that electrode temperatures of 39  –  41  °  C 
would be less damaging to the skin, since these 
temperatures are reached during systemic fever.     
  Patients and methods 
  The study was conducted in the NICU at the 
Copenhagen University Hospital, Rigshospitalet. 
The local ethics committee approved the study 
(J. nr. (KF) 01 283061). Parental consent was 
obtained in all cases. 
  This paper consists of two studies. In the ﬁ  rst 
study, pCO2 precision was examined at ﬁ  ve different 
electrode temperatures (39, 40, 41, 42 and 44  °  C). 
Recruitment was from January to April 2006. Inclu-
sion criteria were clinical indication of transcutane-
ous (TC) monitoring and presence of an umbilical 
or radial arterial catheter. A total of 20 newborns 
irrespective of gestational age (GA) were included 
(      GA mixed group). 
  In the second study, based on results from study 
one, comparisons of pCO2 precision at selected elec-
trode temperatures were done (40, 41 and 44  °  C). 
Recruitment was from November 2006 to June 2008. 
Inclusions criteria was GA below 34 weeks or birth 
weight below 1500 g, clinical indication of TC mon-
itoring and presence of an umbilical or radial arterial 
catheter. A total of 20 preterm infants were included 
(      Preterm group). Inclusion and examination was 
within the neonatal period (ﬁ  rst 28 days of life). 
  All newborns were monitored using two TC 
monitors simultaneously (TCM 4 with combined 
CO  2  /O  2  electrode E5280, Radiometer Medical 
ApS, Denmark). Because of higher values of pCO2 
when elevating skin temperature (anaerobic factor    
4.5%/  °  C), the CO  2  production of epidermal cells 
(  ‘  metabolic  ’   constant) adding to the pCO2 measured 
transcutaneously, the monitor has a correction 
algorithm integrated [11]. We used standard recom-
mendations with the anaerobic factor (Severinghaus 
constant) turned on, and with a metabolic constant 
set at 0.5 kPa. 
  Using two TCM4 simultaneously in the ﬁ  rst 
study, allowed one electrode to remain unchanged at 
44  °  C while the temperature of the other electrode 
was increased every half hour (39, 40, 41, 42 and 
44  °  C) (Figure 1). 
  Using two TCM4 simultaneously in the second 
study allowed a cross over design to investigate the 
impact of preheating of the skin on pCO2 precision 
(Figure 1). 
  The TC electrodes were ﬁ  xed to the skin of the 
trunk using a sticky ﬁ   xation ring (E5260/E5280: 
Fixation ring 904   –   891; 30 mm; Radiometer Medical 
ApS, Denmark). The localization was not changed 
during the study. The electrode housing was 15 mm 
in diameter. After a few droplets of an electrolyte 
solution enhancing contact between electrode and skin, 
the electrode was ﬁ  xed in the ﬁ  xation ring (Electrolyte 
solution; Radiometer Medical ApS, Denmark). 
  The   ‘  gold standard  ’   to which the TC values were 
compared was the arterial pCO2 (PaCO2). 
  All arterial blood samples were taken from the 
indwelling catheter. Blood was sampled in heparin-
ized capillary tubes (100 microliter). Immediately 
after sampling the tube was turned slowly 20 times. 
Within 5 min the blood gases were analysed using 
Blood Gas Analyzer ABL 735 (Radiometer Medical 
ApS, Denmark). In the second study, the ﬁ  rst blood 
sample was analysed in duplicate to estimate 
test-retest variation of arterial pCO2. 
  Arterial blood gas sampling and readings of 
the tcPCO2-level was done simultaneously. After 
changing the electrode temperature, a minimum of 
30 min. was allowed for temperature equilibration 
and for stabilizing tcPCO2 before blood sampling. 
Before measuring at a new electrode temperature, 
the sensor was calibrated. The monitor automatically 
performs this process using a built in calibration 
module and gas cylinder. Calibration of the sensor is 
recommended as a routine procedure in TC moni-
toring using TCM4. The sensor was re-membraned 
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when needed (E5260/E5280: Membrane 904   –   892; 
Radiometer Medical ApS, Denmark). 
  Statistical analysis was done using SPSS version 
12.0 (Chicago). To estimate the repeatability of the 
blood gas analysis we calculated the standard devia-
tion of the differences between the pairs of blood gas 
measurements. Univariate ANOVA was used to test 
the inﬂ  uence of electrode temperature on accuracy 
(  Δ  tcPCO2   –   PaCO2). 95% limits of agreement were 
calculated as described by Bland and Altman [12]. 
As the difference between transcutaneous and arte-
rial pCO2 increased with increasing pCO2, the dif-
ference between transcutaneous and arterial values 
was expressed as a percentage of the mean (100       
(diff. tcPCO2   –   PaCO2/mean tcPCO2   –   PaCO2)). 
The Kruskal-Wallis test was used for comparisons.     
  Results 
  The median gestational age in the GA mixed group 
was 31.1 weeks [24.9; 41.7] and median birth weight   
1822 g [735; 3800 g] (Table I). 
  Diagnoses were manifold: Prematurity (  n       11), 
asphyxia (  n        1), meconium aspiration syndrome 
(  n        1), necrotizing enterocolitis (  n       1),  congenital 
heart disease (  n        3), oesophageal atresia (  n       1), 
extracorporeal membrane oxygenation (  n       1)  and 
no diagnosis speciﬁ  ed (  n       2). 
  In the preterm group, the median gestational 
age was 28.9 weeks [25.6; 32.0] and median birth 
weight 1006 g [590 g; 1900 g] (Table I). All infants 
(  n        20) were preterm, however other diagnoses 
included pneumothorax (  n        4), rhesus immuniza-
tion (  n        1), persistent fetal circulation (  n       1)  and 
lung bleeding (  n       1). 
  No infants were excluded due to instability, 
since this was not a part of the protocol. However, if 
there were any events that potentially could inﬂ  uence 
results, it was remarked. In the GA mixed group, two 
infants had remarks:   ‘  restless  ’   (  n       1)  and   ‘  apnoea, 
bradycardia and desaturation of prematurity  ’   (  n       1), 
while in the preterm group four infants had remarks: 
  ‘  restless  ’   (  n       2),  ‘  increasing oxygen demand  ’   (  n       2), 
  ‘  apnoea, bradycardia and desaturation of prematu-
rity  ’   (  n       4). 
  Arterial pCO2 (  n        220) was normally distrib-
uted (range 3.2  –  7.9; mean 5.8 kPa        1.0 kPa) and 
was not associated with electrode temperature 
(  p        0.9). The repeatability of arterial pCO2 mea-
surements (  n        19) was 0.07       0.15  kPa. 
  By deﬁ  ning a maximum of 1 kPa bias between 
tcPCO2 and PaCO2, we examined how many of 
the paired samples met these qualiﬁ  cations. When 
using an electrode temperature of 39  °  C 45% had 
a bias below 1 kPa (9/20 measurements), at 40  °  C 
73% (44/60 measurements), at 41  °  C 68% (27/40 
measurements), at 42  °  C 90% (18/20 measurements) 
and at 44  °  C 94% had a bias below 1 kPa (75/80 
measurements). 
  The mean PaCO2   -   tcPCO2 difference (bias) 
increased from 5% at 44  °  C to 17% at 39  °  C, but 
did not differ signiﬁ  cantly between 41  °  C and 40  °  C 
(median 14.8% vs. 11.8%) (Figures 2   &   3). The 
precision of the tcPCO2 at each temperature ranged 
from 7  –  10%. After correction for the temperature-
dependent overreading, we found increasing PaCO2   -   
tcPCO2 difference with increasing PaCO2, an approx. 
2% pr. kPa increase of pCO2. 
  All outliers were above the 95% conﬁ  dence 
interval. These outliers occurred primarily at low 
electrode temperature. Sequence of electrode temper-
atures, including preheating of the skin to 44  °  C, had 
no inﬂ   uence on precision. We did not ﬁ  nd  any 
signiﬁ  cant electrode drift after each session by con-
trol measurement using the calibration gas. No skin 
lesions apart from mild transient erythema were 
observed.     
    Table I. Group characteristics.   
GA mixed group 
(  N       20)
Preterm group 
(  N       20)
Gestational age (weeks) 31.1 [24.9; 41.7] 28.9 [25.6; 32.0]
BW (grams) 1822 [735; 3800] 1006 [590; 1900]
Nasal CPAP/Mechanical
ventilation
50%/35% 55%/45%
No oxygen demand 55% 30%
Oxygen supplement 
(% O2)
21% [21%; 55%] 28% [21%; 70%]
Dopamine 0% 10%
   
Figure 2. The difference between transcutaneous pCO2 and 
arterial pCO2 increases at lower electrode temperatures. The 
median difference is     12% at 40  –  41  °  C. Outliers also occur at 
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  Discussion 
  The aim of this study was to investigate how reduction 
of the electrode temperature inﬂ  uences accuracy and 
precision in tcPCO2 measurements in newborn 
infants. Lower electrode temperature reduces the risk 
of skin burning and allows longer periods of continued 
monitoring [13]. 
  The bias of tcPCO2 using the normal electrode 
temperature of 44  °  C was approximately 5%. We had 
set the metabolic constant at 0.53 kPa (4 mmHg), 
which appears to be too low for our population. 
  Lower electrode temperatures were associated 
with higher bias, but at 41  °  C the bias was still 
typically less than 1 kPa. Precision was unchanged. 
We therefore conclude that it is reasonable to moni-
tor tcPCO2 with a temperature of 41  °  C, particularly 
if the bias of 12  –  15% is accounted for. However, 
changing the electrode temperature requires an 
increased clinical awareness. With measurements 
close to the normal PaCO2 range an error of 1 kPa 
will have no great consequences, however readings 
in the subnormal range of PaCO2 can have a sig-
niﬁ  cant impact on cerebral perfusion. On our ward, 
we recommend an arterial blood gas if there is any 
doubt of the actual level of PaCO2 and in particular 
if the tcPCO2 is out of the normal range. At 41  °  C, 
the tcPO2 cannot be relied upon, because the capil-
lary bed will not be sufﬁ  ciently  arterialized. The 
best procedure would be to deactivate the pO2 read-
out of the TCM4. In most situations, oxygen treat-
ment of newborns can be sufﬁ  ciently monitored by 
pulseoximetry. 
  Our results agree reasonably with previous studies. 
A study in neonates found a good correlation between 
tcPCO2 and arterial CO  2   at 42  °  C and even 37  °  C [7]. 
In adults, a good correlation was found between trans-
cutaneous and capillary pCO2 at 37, 39, 41, 43 and 
45  °  C, provided the skin was preheated to 45  °  C [14]. 
The correlation coefﬁ   cient, however, ignores bias. 
Fanconi and colleagues reduced the electrode tem-
perature to 42  °  C and had reliable results, but only 
after topical metabolic inhibition [13]. Furthermore, 
after 12 h continuous use some neonates had skin 
burns [13]. In adults, the TOSCA with an electrode 
temperature of 42  °  C had a bias of        0.02 kPa, only 
[15]. The TOSCA monitor initially preheats the skin 
to 45  °  C for rapid arterialization before measurements 
and measurements were performed at the earlobe, using 
an ear clips. We did not ﬁ  nd any effect of using high 
temperature before low temperature, or vice versa. 
  Surprisingly, in our study the bias was pCO2-
dependent. The transcutaneous electrode uses an 
electrochemical principle: tcPCO2 is measured by 
determining the pH of an electrolyte layer separated 
from the skin by a highly permeable membrane. 
Diffusing CO  2   changes the pH of the electrolyte 
solution and the pH changes are proportional to the 
logarithm of pCO2-changes. Since tissue heating 
increases tissue pCO2 by 4.5%/  °  C and some CO  2   is 
produced locally, the tcPCO2 is higher than the arte-
rial pCO2 and corrections for this are included in 
the monitor. For optimal use, the electrolyte and 
membrane must be changed every week, and the sen-
sor must also be calibrated whenever a new patient 
is monitored. This was done meticulously for our two 
experimental monitors and furthermore control 
measurements using the calibration gas were done 
after measurements in all infants. If out of the accept-
able range, recalibration and/or change of membrane 
was done. Therefore we cannot explain the pCO2 
dependency of the bias. Combined with the upwards 
skew of the distribution of transcutaneous-arterial 
pCO2 difference, it meant that occasionally tcPCO2 
overestimated signiﬁ  cantly, and this occurred more 
often at high arterial tcPCO2. In practical terms this 
means that a very high tcPCO2 must be used with 
care. Safe practice would be taking a blood sample 
before signiﬁ  cant clinical action, e.g. intubation for 
mechanical ventilation. 
  In conclusion, a lower transcutaneous electrode 
temperature increases the systematic overreading of 
tcPCO2. Monitoring at 40 or 41  °  C, however, appears 
reasonable since the typical bias is less than 1 kPa. In 
some cases with high arterial pCO2 the overreading 
was clinically signiﬁ  cant and care should be taken that 
this does not have undue clinical consequences. 
                  Acknowledgements 
  We are grateful to all the parents who allowed the 
participation of their infants. Radiometer Copenhagen 
    Figure 3. This ﬁ   gure shows the mean pCO2 (kPa) versus the 
temperature corrected bias of TcPCO2 (fraction, %). The 
horizontal lines show the mean bias of TcPCO2 at 40  °  C (12%) 
and 44  °  C (5%). Correction with 12  –  15% when using 40  °  C will 
approximate measurements to the arterial pCO2.   552     L. C. S  ø  rensen et al.     
provided the two experimental monitors and all 
consumables, and provided part of the salary for 
LBA. Radiometer did not take part in the study itself, 
data analysis, result presentation or preparation of 
the manuscript.     
Declaration of interest: The authors report no 
conﬂ  ict of interest. The authors alone are responsible 
for the content and writing of the paper.
  References 
    Greisen G, Munck H, Lou H. May hypocarbia cause ischae- [1] 
mic brain damage in the preterm infant? Lancet 1986; 
2:460.   
    Boyle RJ, Oh W. Erythema following transcutaneous PO2  [2] 
monitoring. Pediatrics 1980;65:333  –  4.   
    Golden SM. Skin craters   –   a complication of transcutaneous  [3] 
oxygen monitoring. Pediatrics 1981;67:514  –  6.   
    Moritz AR, Henriques FC. Studies of thermal injury: II.  [4] 
The relative importance of time and surface temperature 
in the causation of cutaneous burns. Am J Pathol 1947;23: 
695  –  720.   
    Monaco F, McQuitty JC, Nickerson BG. Calibration of a  [5] 
heated transcutaneous carbon dioxide electrode to reﬂ  ect 
arterial carbon dioxide. Am Rev Respir Dis 1983;127:
322  –  4.   
    Hazinski TA, Severinghaus JW. Transcutaneous analysis of  [6] 
arterial PCO2. Med Instrum 1982;16:150  –  3.   
    Herrell N, Martin RJ, Pultusker M, Lough M, Fanaroff A.  [7] 
Optimal temperature for the measurement of transcutaneous 
carbon dioxide tension in the neonate. J Pediatr 1980;97: 
114  –  7.   
    Brunstler I, Enders A, Versmold HT. Skin surface PCO2  [8] 
monitoring in newborn infants in shock: effect of hypo-
tension and electrode temperature. J Pediatr 1982;100:
454  –  7.   
    Friis-Hansen B, Voldsgaard P, Witt J, Pedersen KG,  [9] 
Frederiksen PS. The measurement of TcPO2 and TcPCO2 
in newborn infants at 44 degrees C, 42 degrees C and 
37 degrees C after initial heating to 44 degrees C. Adv Exp 
Med Biol 1987;220:35  –  40.   
    Nishiyama T, Nakamura S, Yamashita K. Comparison of  [10] 
the transcutaneous oxygen and carbon dioxide tension in 
different electrode locations during general anaesthesia. 
Eur J Anaesthesiol 2006;23:1049  –  54.   
    Eberhard P. The design, use, and results of transcutaneous  [11] 
carbon dioxide analysis: current and future directions. 
Anesth Analg 2007;105:S48  –  S52.   
    Bland JM, Altman DG. Applying the right statistics: analyses  [12] 
of measurement studies. Ultrasound Obstet Gynecol 2003; 
22:85  –  93.   
    Fanconi S, Tschupp A, Molinari L. Long-term transcutane- [13] 
ous monitoring of oxygen tension and carbon dioxide at 
42 degrees C in critically ill neonates: improved perfor-
mance of the tcpo2 monitor with topical metabolic inhibi-
tion. Eur J Pediatr 1996;155:1043  –  6.   
    Wimberley PD, Gronlund PK, Olsson J, Siggaard-Andersen  [14] 
O. Transcutaneous carbon dioxide and oxygen tension 
measured at different temperatures in healthy adults. Clin 
Chem 1985;31:1611  –  5.   
    McVicar J, Eager R. Validation study of a transcutaneous  [15] 
carbon dioxide monitor in patients in the emergency depart-
ment. Emerg Med J 2009;26:344  –  6.       